TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2015

Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.

Amin M Alousi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.